Grander Closes Acquisition Of Polarityte, Inc. Assets
08/22/23, 12:57 PM
Industry
biotechnology
health care
Grander Acquisition LLC (the "Company"), an entity led by Michael Brauser, announced the Company has closed on its acquisition of substantially all of the assets of RegenETP, Inc. (formerly known as PolarityTE, Inc.), a biotechnology company that had been developing regenerative tissue products.
Company Info
Company info
Grander Acquisition LLC, headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. Grander Acquisition LLC's first regenerative tissue product is SkinTE®. Grander Acquisition LLC has an open investigational new drug application (IND) for SkinTE® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE® is available for investigational use only. Learn more at www.PolarityTE.com.
Media Contact:
John Stetson
561-351-3777
364164@email4pr.com
SOURCE Grander Acquisition